-+ 0.00%
-+ 0.00%
-+ 0.00%

AN2 PROVIDES STRATEGIC UPDATE FOR PHASE 3 EBO-301 TRIAL IN TREATMENT REFRACTORY MAC LUNG DISEASE

Reuters·02/24/2025 12:00:02

Please log in to view news